TY - JOUR
T1 - National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis
AU - Gori, Niccolo'
AU - Chiricozzi, Andrea
AU - Marsili, Franco
AU - Ferrucci, Silvia Mariel
AU - Amerio, Paolo
AU - Battarra, Vincenzo
AU - Campitiello, Salvatore
AU - Castelli, Antonio
AU - Congedo, Maurizio
AU - Corazza, Monica
AU - Cristaudo, Antonio
AU - Fabbrocini, Gabriella
AU - Girolomoni, Giampiero
AU - Malara, Giovanna
AU - Micali, Giuseppe
AU - Palazzo, Giovanni
AU - Parodi, Aurora
AU - Patrizi, Annalisa
AU - Pellacani, Giovanni
AU - Pigatto, Paolo
AU - Provenzano, Eugenio
AU - Quaglino, Pietro
AU - Romanelli, Marco
AU - Rossi, Mariateresa
AU - Savoia, Paola
AU - Peris, Ketty
PY - 2022
Y1 - 2022
N2 - Atopic dermatitis (AD) is a common inflammatory skin disease often associated with a significant impairment in the quality of life of affected patients. The Italian Society of Dermatology and Venereology (SIDeMaST) planned a national information campaign, providing direct access to 27 dermatologic centers dedicated to the management of AD. The aim of this study aimed was to outline critical aspects related to AD in the general population. Overall, 643 adult subjects were included in this study, and in 44.2% (284/643) of cases, a diagnosis of AD was confirmed, whereas about 55% of subjects were affected by other pruritic cutaneous diseases. Higher intensity of pruritus and sleep disturbance, as well as an increased interference in sport, work, and social confidence was reported in the AD group compared to the non-AD group. In the AD subgroup, the mean duration of disease was of 15.3 years, with a mean eczema area and severity index (EASI) score of 11.2, and investigator global assessment (IGA) score of 1.9 and an itch numeric rating scale (NRS) of 6.9. Almost 32% of patients were untreated, either with topical or systemic agents, whereas 44.3% used routine topical compounds (topical corticosteroids and calcineurin inhibitors), and only 7.0% of patients were systemically treated. Only 2.8% of patients reported complete satisfaction with the treatment received for AD to date. This study reveals a profound unmet need in AD, showing a poorly managed and undertreated patient population despite a high reported burden of disease. This suggests the usefulness of information campaigns with the goal of improving patient awareness regarding AD and facilitating early diagnosis and access to dedicated healthcare institutions.
AB - Atopic dermatitis (AD) is a common inflammatory skin disease often associated with a significant impairment in the quality of life of affected patients. The Italian Society of Dermatology and Venereology (SIDeMaST) planned a national information campaign, providing direct access to 27 dermatologic centers dedicated to the management of AD. The aim of this study aimed was to outline critical aspects related to AD in the general population. Overall, 643 adult subjects were included in this study, and in 44.2% (284/643) of cases, a diagnosis of AD was confirmed, whereas about 55% of subjects were affected by other pruritic cutaneous diseases. Higher intensity of pruritus and sleep disturbance, as well as an increased interference in sport, work, and social confidence was reported in the AD group compared to the non-AD group. In the AD subgroup, the mean duration of disease was of 15.3 years, with a mean eczema area and severity index (EASI) score of 11.2, and investigator global assessment (IGA) score of 1.9 and an itch numeric rating scale (NRS) of 6.9. Almost 32% of patients were untreated, either with topical or systemic agents, whereas 44.3% used routine topical compounds (topical corticosteroids and calcineurin inhibitors), and only 7.0% of patients were systemically treated. Only 2.8% of patients reported complete satisfaction with the treatment received for AD to date. This study reveals a profound unmet need in AD, showing a poorly managed and undertreated patient population despite a high reported burden of disease. This suggests the usefulness of information campaigns with the goal of improving patient awareness regarding AD and facilitating early diagnosis and access to dedicated healthcare institutions.
KW - atopic dermatitis
KW - early diagnosis
KW - information campaign
KW - atopic dermatitis
KW - early diagnosis
KW - information campaign
UR - http://hdl.handle.net/10807/229013
U2 - 10.3390/jcm11175204
DO - 10.3390/jcm11175204
M3 - Article
SN - 2077-0383
VL - 11
SP - 5204-N/A
JO - Journal of Clinical Medicine
JF - Journal of Clinical Medicine
ER -